Ben Oshrine

Company: Legend Biotech

Job title: Senior Medical Director, Early Clinical Development

Seminars:

Exploring New Targets in Solid Tumors to Improve Tumor Specificity & Reduce Off- Target Toxicities 11:30 am

Assessing the need for new target identification in solid tumors Identifying potential new targets such as Claudin 18.2, HER2 and EFGR that can help with increasing tumor specificity Understanding how to develop cell therapies for the new targetsRead more

day: Post-Conference Solid Tumor Focus Day